Study to Evaluate Chronic Myeloid Leukemia Treatment Landscape and Real-life Treatment Outcomes in Hungary: Analysis of National Health Insurance Fund Database
Condition: Chronic Myeloid Leukaemia Interventions: Drug: Bosutinib; Drug: Imatinib; Drug: Nilotinib; Drug: Dasatinib; Drug: Ponatinib Sponsor: Pfizer Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Databases & Libraries | Gleevec | Health Insurance | Hungary Health | Insurance | Leukemia | Nilotinib | Pfizer | Research | Study | Tasigna